大鼠SR-BI胞外域与ApoA-Ⅰ蛋白相互作用的确认

先以含全长SR-BI cDNA序列的重组质粒pMD18-T-rS为摸板进行PCR反应扩增SR-BI得到胞外域cDNA片段,经测序证明正确后,定向克隆到酵母双杂交表达载体,然后与pGBKT7-ApoA-Ⅰ质粒共转化酵母细胞,通过报告基因及酵母交配试验确认了SR-BI的胞外域部分和ApoA-Ⅰ之间的确存,观察到ApoA-Ⅰ与SR-BI胞外域间的相互作用力比与全长的SR-BI问的相互作用力提高了10％。     

用酵母双杂交系统研究载脂蛋白AI(apoAI)和清道夫受体BI(SR-BI)间的相互作用

目的:利用酵母双杂交系统验证在胆固醇逆转运过程中起关键作用的大鼠载脂蛋白AI(apoAI)和清道夫受体BI-(SR-BI)间存在着相互作用,为初步筛选具有降脂活性组分提供1对新的靶点。方法:首先分别克隆了Wistar大鼠的apoAI和SR-BI基因的cDNA,并构建了酵母表达载体,利用共转化技术观察到apoAI和SR-BI间存在着相互作用,并在酵母交配实验中证实了这个结果。结果:经共转化后的实验组与阳性对照组可在SD/-Leu/-Trp/-His/-Ade/X-α-Gal平板上生长且菌斑呈蓝色,经测定α、β半乳糖苷酶活力可知酶活分别为8～12U和10～40U。酵母交配后的二倍体实验组、阳性对照组可在SD/-Leu/-Trp/-His/-Ade/X-α-Gal平板上生长且菌斑呈蓝色。结论:apoAI和SRBI间的确存在相互作用。     

SR-BI及其伴侣分子PDZK1在HCV入侵中的作用

B族Ⅰ型清道夫受体（scavenger receptor class B type I,SR-BI）是丙型肝炎病毒（hepatitis C virus,HCV）的受体之一,可以与HCV的包膜蛋白E2结合,介导病毒颗粒进入宿主细胞。伴侣分子PDZK1（PDZdomain containing 1）是一个含有4个PDZ结构域的支架蛋白,其第一个PDZ结构域可以与SR-BI的C端结合,调节其稳定表达和正确定位。研究发现PDZK1基因敲除以后,HCVcc（cell culture produced HCVvirus）和HCVpp（HCV pseudotype particles）的感染性明显下降;重新转入PDZK1后,可以部分恢复感染性。研究表明PDZK1可促进HCV入侵并可能是通过与SR-BI的相互作用介导的。伴侣分子对受体分子的调节在HCV入侵中的作用可能成为HCV治疗的潜在靶标,有助于开发新的治疗方法。     

利用酵母双杂交系统筛选水稻类受体激酶OsWAK50胞内域相互作用蛋白

细胞壁连接的类受体激酶(wall-associated kinase,WAK)是植物细胞中一类特有的类受体激酶基因亚家族,因其胞外域与细胞壁紧密相连而得名．水稻中共有125个OsWAK基因,OsWAK50编码的蛋白质具有胞外域、跨膜域和激酶域,呈现典型的WAK样受体激酶特征．首先通过对OsWAK50-GFP融合蛋白的观察发现OsWAK50定位于细胞膜并且与细胞壁偶联．进而通过酵母双杂交系统筛选到了20个可能与OsWAK50胞内域相互作用的候选蛋白,并通过一对一酵母转化验证了OsSK4、OsSWIB和OsSWI3C全长均可与OsWAK50胞内域相互作用．进一步分析显示,OsSWIB能够直接与OsWAK50激酶域互作,而OsSK4和OsSWI3C与OsWAK50胞内域的互作是依赖于OsWAK50 C端的．研究还表明,OsSK4和OsSWIB亦能与OsWAK50同源基因OsWAK53a结合,而OsSWI3C则不能与OsWAK53a结合．双分子荧光互补实验证明,OsSK4与OsWAK50和OsWAK53a能够在植物体内发生互作．以上结果为阐明OsWAK50发挥功能的分子机制提供了重要线索．     

酵母双杂交筛选类固醇激素合成急性调节蛋白的相互作用蛋白质

目的:利用酵母双杂交技术筛选人肝cDNA文库中与类固醇激素合成急性调节蛋白(STAR)相互作用的蛋白质。方法:将全长STAR基因克隆到酵母表达载体pDBLeu中,形成诱饵;将构建好的诱饵质粒转化至AH109酵母感受态中,利用酵母双杂交技术筛选人肝cDNA文库中与其相互作用的蛋白质,并进行相互作用的回转验证。结果:构建了酵母诱饵蛋白表达质粒pDBLeu-STAR,并筛选到6个猎物,其中有5对相互作用回转验证阳性。结论:为进一步研究STAR的功能和作用机制提供了新的线索。     

用酵母双杂交系统筛选影响apo-AI和SR-BI相互作用的苦豆子活性成分

本文通过将苦豆子总提取物及其分离得到的10个组分加入含有AH109菌株(携带大鼠apo-AI及其受体SR-BI全基因)的培养基中,利用报告基因半乳糖苷酶活力有无变化来寻找能够促进大鼠载脂蛋白apo-AI及其受体SR-BI相互作用的激动剂.经测试,我们观察到苦豆子总提取物(K-1),在上述系统中能显著增强这两种蛋白的相互作用.继续用硅胶柱层析方法从k-1中分出10个组分后,利用酵母双杂交系统再次筛选,发现有五个组分能增强两种蛋白的相互作用,(与空白对照组相比其中有两个组分有极显著差异)另外三个组分显著地抑制上述两种蛋白的相互作用,剩下的两个组分则没有差异.该实验还提示该酵母双杂交系统可能成为一种跟踪具有调脂功能的先导化合物的有效方法.     

鸭圆环病毒Cap基因酵母双杂交诱饵载体的构建及鉴定

为构建鸭圆环病毒Cap基因酵母双杂交诱饵载体,以本实验室分离鉴定的DuCV GH01株Cap基因为模板,对其进行酵母密码子优化后,连接到pGBKT7载体上构建诱饵质粒,经菌落PCR、酶切鉴定以及测序后,转化酵母菌株Y2HGold感受态,检测诱饵蛋白表达以及诱饵蛋白对酵母细胞毒性和自激活现象。结果表明,优化后的Cap基因全长774bp,成功连接到诱饵载体pGBKT7中,重组质粒pGBKT7-Cap转入酵母细胞后,Western blot检测到50kD左右的蛋白条带,诱饵蛋白对酵母细胞既无毒性,又没有自激活现象。为进一步利用酵母双杂交技术筛选与Cap蛋白互作的蛋白奠定了基础。     

人骨形态发生蛋白2(BMP-2)在巴斯德毕赤酵母中的表达

以重组质粒pUC-BMP2为模板PCR扩增人BMP-2成熟肽编码序列,将该序列克隆入pGEM-T载体进行DNA序列分析后亚克隆入分泌型毕赤酵母表达载体pPIC9K中。重组质粒oPIC9K-BMP2经BelⅡ酶切后回收线性化片段,聚乙二醇法转染毕赤酵母茵株GS115。PCR筛选整合有人BMP-2基因的酵母细胞重组子,以甲醇进行诱导表达,于酵母细胞培养基中可检测到rhBMP-2。体外培养条件下,所得rhBMP-2可增加2T3小鼠成骨细胞内碱性磷酸酶活性;体内实验．rhBMP-2冻干粉可于小鼠骨四头肌肌袋中诱导软骨细胞群产生。     

抗菌肽牛乳铁多肽素（LfcinB）在毕赤酵母中的表达及活性鉴定

利用巴斯德毕赤酵母(Pichia pastors)系统表达抗菌肽——牛乳铁多肽素(bovine lactoferricin,简称Lf-cinB),获得的分泌型表达产物具有较强的抗菌活性。首先将人工合成的LfcinB基因片段克隆到巴斯德毕赤酵母分泌型表达载体pPIC9K中,获得的重组质粒pPIC9K-LfcinB通过限制性内切酶SalⅠ酶切线性化,经电穿孔法转化入毕赤酵母细胞SMD1168内。G418抗性筛选,得到高拷贝转化子,经PCR检测LfcinB基因与毕赤酵母染色体稳定整合。阳性克隆经甲醇诱导表达LfcinB。结果表明,抗菌肽牛乳铁多肽素基因已经整合到酵母细胞基因组中并获得表达,表达产物具有较强的杀菌作用。     

带3蛋白C端和血型糖蛋白A相互作用及其抗原相关性的研究

采用高效液相色谱法分离鉴定了红细胞膜蛋白质跨膜域的亲水性肽链,结果显示血型糖蛋白A(GPA)Lys101～Asp130与带3蛋白有相关性.为进行深入研究,采用RT-PCR方法从K562细胞中扩增了410 bp的GPA基因,分别克隆到酵母双杂交BD端表达质粒和杆状病毒转移载体上.同时,以含有带3蛋白全长基因的质粒为模板扩增了348 bp的带3蛋白C端基因,将其克隆到酵母双杂交AD端表达质粒.经酵母双杂交营养缺陷培养选择和β半乳糖苷酶检测证实GPA与带3蛋白之间存在相互作用.GPA表达产物分别经抗带3蛋白和抗GPA抗体进行蛋白质印迹分析,表明二者具有免疫交叉反应.上述结果表明带3蛋白与GPA在结构与功能上存在着密切联系.     

人端粒逆转录酶与Snapin蛋白相互作用的鉴定

目的:研究人端粒逆转录酶(hTERT)与Snapin蛋白的相互作用。方法:将hTERT基因和Snapin基因分别构建到pGBKT7和pGADT7载体中,用酵母双杂交方法在酵母中验证其相互作用;在293T细胞中,共转染带有Flag标签的hTERT及带有GFP标签的Snapin质粒,进行免疫共沉淀;将GST融合的Snapin纯化蛋白与hTERT进行GST-pull down,验证其相互作用。结果:3种方法都证明hTERT能够与Snapin相互作用。结论:Snapin蛋白能够与hTERT相互作用,为研究Snapin参与调控端粒酶的功能活动提供了一些线索。     

灰飞虱高带毒（RSV）群体酵母双杂交cDNA文库的构建

为了研究灰飞虱Laodelphax striatellus Fallén与水稻条纹病毒（rice stripe virus, RSV）互作机制, 本研究构建了灰飞虱高带毒群体酵母双杂交cDNA文库。以实验室筛选的灰飞虱高带毒群体为材料, 分离纯化mRNA, 反转录合成双链cDNA, 并连接三框型接头, 层析柱分级纯化。采用同源重组反应制备三框型cDNA入门文库, 再通过同源重组将入门文库转移到Gateway兼容载体pGADT7-DEST上, 构建获得酵母双杂交cDNA文库。检测结果表明： 文库库容量为3.68×10⁷ cfu, 扩增文库滴度为2.62×10¹⁰ cfu/mL; 文库重组率大于95%, cDNA插入片段平均长度>1 kb, 达到了标准cDNA文库的要求。灰飞虱高带毒群体酵母双杂交cDNA文库的构建为开展昆虫介体与水稻条纹病毒互作机制的研究奠定了基础。     

HeLa细胞cDNA文库及酵母双杂交诱饵载体pGBKT7-CPn0308的构建

旨在利用酵母双杂交系统构建HeLa细胞的cDNA文库,并构建酵母双杂交诱饵载体pGBKT7-CPn0308。从HeLa细胞中提取总RNA,应用SMARTTM技术,构建以pGADT7-Rec为载体的HeLa细胞酵母GAL4 AD融合cDNA文库。应用PCR技术扩增目的片段CPn0308,并成功克隆该基因到诱饵载体pGBKT7中,将重组质粒转化酵母菌株AH109后,检测诱饵载体有无自激活和细胞毒性作用。结果显示,文库展现良好的多态性,重组诱饵载体pGBKT7-CPn0308不具有毒性且未自主激活报告基因,说明该文库和诱饵质粒可用于酵母双杂交系统。     

Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis

Scavenger receptor SR-BI significantly contributes to HDL cholesterol metabolism and atherogenesis in mice. However, the role of SR-BI may not be as pronounced in humans due to cholesteryl ester transfer protein (CETP) activity. To address the impact of CETP expression on the adverse effects associated with SR-BI deficiency, we cross-bred our SR-BI conditional knock-out mouse model with CETP transgenic mice. CETP almost completely restored the abnormal HDL-C distribution in SR-BI-deficient mice. However, it did not normalize the elevated plasma free to total cholesterol ratio characteristic of hepatic SR-BI deficiency. Red blood cell and platelet count abnormalities observed in mice liver deficient for SR-BI were partially restored by CETP, but the elevated erythrocyte cholesterol to phospholipid ratio remained unchanged. Complete deletion of SR-BI was associated with diminished adrenal cholesterol stores, whereas hepatic SR-BI deficiency resulted in a significant increase in adrenal gland cholesterol content. In both mouse models, CETP had no impact on adrenal cholesterol metabolism. In diet-induced atherosclerosis studies, hepatic SR-BI deficiency accelerated aortic lipid lesion formation in both CETP-expressing (4-fold) and non-CETP-expressing (8-fold) mice when compared with controls. Impaired macrophage to feces reverse cholesterol transport in mice deficient for SR-BI in liver, which was not corrected by CETP, most likely contributed by such an increase in atherosclerosis susceptibility. Finally, comparison of the atherosclerosis burden in SR-BI liver-deficient and fully deficient mice demonstrated that SR-BI exerted an atheroprotective activity in extra-hepatic tissues whether CETP was present or not. These findings support the contention that the SR-BI pathway contributes in unique ways to cholesterol metabolism and atherosclerosis susceptibility even in the presence of CETP.     

Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI

The mitogen-activated protein kinase (MAPK) Erk1/2 has been implicated to modulate the activity of nuclear receptors, including peroxisome proliferator activator receptors (PPARs) and liver X receptor, to alter the ability of cells to export cholesterol. Here, we investigated if the Ras-Raf-Mek-Erk1/2 signaling cascade could affect reverse cholesterol transport via modulation of scavenger receptor class BI (SR-BI) levels. We demonstrate that in Chinese hamster ovary (CHO) and human embryonic kidney (HEK293) cells, Mek1/2 inhibition reduces PPARα-inducible SR-BI protein expression and activity, as judged by reduced efflux onto high density lipoprotein (HDL). Ectopic expression of constitutively active H-Ras and Mek1 increases SR-BI protein levels, which correlates with elevated PPARα Ser-21 phosphorylation and increased cholesterol efflux. In contrast, SR-BI levels are insensitive to Mek1/2 inhibitors in PPARα-depleted cells. Most strikingly, Mek1/2 inhibition promotes SR-BI degradation in SR-BI-overexpressing CHO cells and human HuH7 hepatocytes, which is associated with reduced uptake of radiolabeled and 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyane-labeled HDL. Loss of Mek1/2 kinase activity reduces SR-BI expression in the presence of bafilomycin, an inhibitor of lysosomal degradation, indicating down-regulation of SR-BI via proteasomal pathways. In conclusion, Mek1/2 inhibition enhances the PPARα-dependent degradation of SR-BI in hepatocytes.     

Interaction of scavenger receptor class B type I with peroxisomal targeting receptor Pex5p

Scavenger receptor class B type I (SR-BI) is an HDL receptor that mediates selective HDL lipid uptake. Peroxisomes play an important role in lipid metabolism and peroxisomal targeting signal type 1 (PTS1)-containing proteins are translocated to peroxisomes by the peroxisomal targeting import receptor, Pex5p. We have previously identified a PTS1 motif in the intracellular domain of rat SR-BI. Here, we examine the possible interaction between Pex5p and SR-BI. Expression of a Flag-tagged intracellular domain of SR-BI resulted in translocation to the peroxisome as demonstrated by double labeling with anti-Flag IgG and anti-catalase IgG analyzed by confocal microscopy. Immunoprecipitation experiments with anti-SR-BI antibody showed that Pex5p co-precipitated with SR-BI. However, when an antibody against Pex5p was used for immunoprecipitation, only the 57kDa, non-glycosylated form, of SR-BI co-precipitated. We conclude that the PTS1 domain of SR-BI is functional and can mediate peroxisomal interaction via Pex5p, in vitro.     

Hepatic Scavenger Receptor BI Protects Against Polymicrobial-induced Sepsis through Promoting LPS Clearance in Mice

Recent studies revealed that scavenger receptor BI (SR-BI or Scarb1) plays a critical protective role in sepsis. However, the mechanisms underlying this protection remain largely unknown. In this study, using Scarb1^I179N mice, a mouse model specifically deficient in hepatic SR-BI, we report that hepatic SR-BI protects against cecal ligation and puncture (CLP)-induced sepsis as shown by 75% fatality in Scarb1^I179N mice, but only 21% fatality in C57BL/6J control mice. The increase in fatality in Scarb1^I179N mice was associated with an exacerbated inflammatory cytokine production. Further study demonstrated that hepatic SR-BI exerts its protection against sepsis through its role in promoting LPS clearance without affecting the inflammatory response in macrophages, the glucocorticoid production in adrenal glands, the leukocyte recruitment to peritoneum or the bacterial clearance in liver. Our findings reveal hepatic SR-BI as a critical protective factor in sepsis and point out that promoting hepatic SR-BI-mediated LPS clearance may provide a therapeutic approach for sepsis.